LONDON (ShareCast) - (Sharecast News) - Surgical endoscopy device company Creo Medical has completed the freehold purchase of its main headquarters in Chepstow, Creo House, it announced on Tuesday.
The AIM-traded firm said it had also acquired the adjacent site, both from the original developer Fastnet Property Investments.

It said the additional capacity would support its commercial, operational and logistic footprint across Europe, following the acquisition of Albyn Medical in July and Boucart Medical in November 2020.

"It will also provide additional manufacturing capacity for the commercial roll-out of the full range of products from the Creo GI suite of advanced energy devices, which complement the company's Croma advanced energy platform and Speedboat device for use in gastrointestinal therapeutic endoscopy," the board said in its statement.

At 0857 BST, shares in Creo Medical were up 3.14% at 197p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE